RIPK3 and colitis: Interestingly, RIPK3 activity can be restricted by ubiquitination of the beyond-the-RHIM (BTR) domain, and its TSC1/mTOR - TRIM11-mediated ubiquitination and degradation in IECs alleviates necroptosis and hence colitis (65, 66).